scispace - formally typeset
Journal ArticleDOI

Histone deacetylase inhibitors.

Claude Monneret
- 01 Jan 2005 - 
- Vol. 40, Iss: 1, pp 1-13
TLDR
Design of a second generation ofHDACs was based upon data affording potent HDACs such as LAQ824 and PDX101 currently under phase I clinical trials, and two of them, MS-275 and CI-994, have reached phase II and I clinical Trials, respectively.
About
This article is published in European Journal of Medicinal Chemistry.The article was published on 2005-01-01. It has received 819 citations till now. The article focuses on the topics: Histone deacetylase & Phenylbutyrate.

read more

Citations
More filters
Journal ArticleDOI

Control of Apoptosis in Treatment and Biology of Pancreatic Cancer

TL;DR: Different intrinsic and extrinsic pathways in pancreatic cancer that may affect apoptosis are focused on to understand its aggressive nature and resistance to conventional treatment modalities.
Journal ArticleDOI

Identification of potential isoform-selective histone deacetylase inhibitors for cancer therapy: a combined approach of structure-based virtual screening, ADMET prediction and molecular dynamics simulation assay.

TL;DR: A large compound library containing 2,703,000 compounds retrieved from Otava database was screened against class I HDACs by exhaustive approach of structure-based virtual screening using rDOCK and Autodock Vina, and a total of 41 compounds were found to show high-isoform selectivity.
Journal ArticleDOI

Natural products: chemical instruments to apprehend biological symphony.

TL;DR: How natural products or engineered analogs can be used as chemical tools to apprehend some biological problems from the point of view of a chemical biologist is emphasized.
Journal ArticleDOI

Alterations in cellular metabolome after pharmacological inhibition of Notch in glioblastoma cells

TL;DR: Global and targeted expression analyses revealed that multiple genes important in glutamate homeostasis, including glutaminase, are dysregulated after Notch inhibition, suggesting that notch inhibition may act at least in part by regulating glutaminases and glutamate.
References
More filters
Journal ArticleDOI

Crystal structure of the nucleosome core particle at 2.8 Å resolution

TL;DR: The X-ray crystal structure of the nucleosome core particle of chromatin shows in atomic detail how the histone protein octamer is assembled and how 146 base pairs of DNA are organized into a superhelix around it.
Journal ArticleDOI

hSIR2SIRT1 Functions as an NAD-Dependent p53 Deacetylase

TL;DR: It is proposed that hSir2, the human homolog of the S. cerevisiae Sir2 protein known to be involved in cell aging and in the response to DNA damage, binds and deacetylates the p53 protein with a specificity for its C-terminal Lys382 residue.
Journal ArticleDOI

Negative Control of p53 by Sir2α Promotes Cell Survival under Stress

TL;DR: It is shown that mammalian Sir2alpha physically interacts with p53 and attenuates p53-mediated functions, and Nicotinamide inhibits an NAD-dependent p53 deacetylation induced by Sir2 alpha, and also enhances the p53 acetylation levels in vivo.
Journal ArticleDOI

Potent and specific inhibition of mammalian histone deacetylase both in vivo and in vitro by trichostatin A.

TL;DR: Results clearly indicate that TSA is a potent and specific inhibitor of the histone deacetylase and that the in vivo effect of TSA on cell proliferation and differentiation can be attributed to the inhibition of the enzyme.
Journal ArticleDOI

Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells

TL;DR: Valproic acid induces differentiation of carcinoma cells, transformed hematopoietic progenitor cells and leukemic blasts from acute myeloid leukemia patients, and tumor growth and metastasis formation are significantly reduced in animal experiments, suggesting that it might serve as an effective drug for cancer therapy.
Related Papers (5)